Large Cannabis Company Earnings Reports Are Ahead

The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. December and January were a slow period for reporting, but February will be more interesting.

Tracker Rules

This data-driven, fact-based tracker will continually update based on new financial filings so that readers can stay up to date. Companies must file with the SEC or SEDAR and be current to be considered for inclusion. When we launched this resource in May 2019, companies with quarterly revenue in excess of US$2.5 million qualified. As the industry has scaled and as more companies have gone public, we have raised the minimum several times subsequently, including a move to US$5 million in October 2019, to US$7.5 million in June 2020, to US$10 million in November 2020 and US$12.5 million in August 2021. Due to the rapid growth in the cannabis industry, we raised the minimum to US$25 million (C$33.4 million) to qualify for what we now call the senior list and introduced a junior list with a minimum of US$12.5 million (C$16.7 million) in September 2021.

A Note About Adjusted Operating Income

In May 2019, we added an additional metric, “Adjusted Operating Income”, as we detailed in our newsletter. The calculation takes the reported operating income and adjusts it for any changes in the fair value of biological assets required under IFRS accounting. We believe that this adjustment improves comparability for the companies across IFRS and GAAP accounting. We note that often operating income can include one-time items like stock compensation, inventory write-downs or public listing expenses, and we recommend that readers understand how these non-cash items can impact quarterly financials. Many companies are moving from IFRS to U.S. GAAP accounting, which will reduce our need to make adjustments. Please note that our rankings include only actual reported revenue and not pro forma revenue. We also note that companies with non-cannabis operations must provide segment-level financial reports that detail not only revenue but also operating profit to be have their operating profit included in the tracker. Currently, Jazz Pharma (NASDAQ: JAZZ) and Tilray (TSX: TLRY) (NASDAQ: TLRY) aren’t providing this information. Please note as well that we updated how we are handling Canopy Growth (TSX: WEED) (NASDAQ: CGC), now excluding the non-cannabis revenue of BioSteel.

Tracker Inclusion Updates

At the time of our last update on November 25th, 39 companies qualified for inclusion on the senior list, including 31 filing in U.S. dollars and 8 in the Canadian currency. Currently, 31 companies that file in U.S. dollars qualify and 8 that file in Canadian dollars are qualifying for the senior lists, a total of now 39. The junior list now includes 7 companies reporting in U.S. dollars and 3 in Canadian dollars. On a combined basis, the Public Cannabis Company Revenue & Income Tracker now includes 49 companies.

Valens, which was acquired recently by SNDL (NASDAQ: SNDL) has been removed from the junior list of companies that report in Canadian dollars. We expect to add additional companies in the months ahead, and, due to pending or recently completed mergers, we anticipate some removals as well. We note that Intercure (TASE: INCR) (NASDAQ: INCR), which reports in the Israeli currency, qualifies for the junior list, but we haven’t yet added it due to its different reporting currency.

Included Companies That Reported in December or January

Since our last update, there haven’t been many companies that have reported, and we had no new additions to the rankings.

Senior – American Dollar Reporting

Tilray Brands (NASDAQ: TLRY) (TSX: TLRY), the only company on the senior list to report since our last update, reported its Q2 ending in November this month, and it was worse than expected for overall revenue and adjusted EBITDA. Cannabis revenue, a minority of overall sales, fell 15% sequentially and from a year ago.

Scotts Miracle-Gro (NYSE: SMG) will report its Q1 on 2/1. The company, according to the consensus calculated by Sentieo, is expected to see overall revenue pick up 2% sequentially while falling 11% from a year ago to $504 million. Analysts project adjusted EBITDA of -$27 million. Most of the other cannabis companies with years ending in December will not be required to report until March, but Green Thumb Industries (OTC: GTBIF) (CSE: GTII) has scheduled its release and a call for 2/28. The company is expected to see Q4 revenue slip 2% sequentially to $257 million, up 5% from a year ago. Analysts project adjusted EBITDA will increase 6% from a year ago to $80 million.

Junior – American Dollar Reporting

There were no reports since our last update, and there are no calls scheduled for February.

Senior and Junior – Canadian Dollar Reporting

Organigram (NASDAQ: OGI) (TSX: OGI) put up a solid report recently for its Q1. Revenue fell a bit sequentially, but it rose 43% from a year ago. The company generated cash from its operations. Other companies that reported in December included HEXO Corp. (NASDAQ: HEXO) (TSX: HEXO) and Fire & Flower (OTC: FFLWF) (TSX: FAF). HEXO results were well below expectations for its Q1, and Fire & Flower fell a bit below expectations for its Q3.

High Tide (NASDAQ: HITI) (TSXV: HITI) reports on 1/30 and hosts a call on 1/31. The company is expected to see Q4 revenue hit C$100 million, up 86% from a year ago, and to produce adjusted EBITDA of C$4 million. Canopy Growth (NASDAQ: CGC) (TSX: WEED) will report its Q3 and host a call on 2/9. It is expected to have produced revenue of C$119 million, down 16% from a year ago, with adjusted EBITDA of -C$64 million. Aurora Cannabis (NASDAQ: ACB) (TSX: ACB) hasn’t released a date for its call yet, but its Q2 report is due by 2/14. The company is projected to see revenue decline by 7% from a year ago to C$56 million. Adjusted EBITDA is expected to improve to -C$4 million.

Stay up to date

Visit the Public Cannabis Company Revenue Tracker to track and explore the complete list of qualifying companies. We have recently created a way for our readers to access our library of Revenue Tracker articles. For our readers who are interested in staying on top of scheduled earnings calls in the sector, we have created and continually update the Cannabis Investor Earnings Conference Call Calendar.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter